271 related articles for article (PubMed ID: 34603036)
21. Erythropoietin, erythropoiesis and beyond.
Chateauvieux S; Grigorakaki C; Morceau F; Dicato M; Diederich M
Biochem Pharmacol; 2011 Nov; 82(10):1291-303. PubMed ID: 21782802
[TBL] [Abstract][Full Text] [Related]
22. Erythropoietin, a novel versatile player regulating energy metabolism beyond the erythroid system.
Wang L; Di L; Noguchi CT
Int J Biol Sci; 2014; 10(8):921-39. PubMed ID: 25170305
[TBL] [Abstract][Full Text] [Related]
23. Erythropoietin-Induced Changes in Bone and Bone Marrow in Mouse Models of Diet-Induced Obesity.
Suresh S; Alvarez JC; Dey S; Noguchi CT
Int J Mol Sci; 2020 Feb; 21(5):. PubMed ID: 32121294
[TBL] [Abstract][Full Text] [Related]
24. Erythropoietin and long-acting erythropoiesis stimulating agent ameliorate non-alcoholic fatty liver disease by increasing lipolysis and decreasing lipogenesis via EPOR/STAT pathway.
Tsuma Y; Mori J; Ota T; Kawabe Y; Morimoto H; Fukuhara S; Kodo K; Umemura A; Nakajima H; Hosoi H
Biochem Biophys Res Commun; 2019 Jan; 509(1):306-313. PubMed ID: 30583863
[TBL] [Abstract][Full Text] [Related]
25. Survival and proliferative roles of erythropoietin beyond the erythroid lineage.
Noguchi CT; Wang L; Rogers HM; Teng R; Jia Y
Expert Rev Mol Med; 2008 Dec; 10():e36. PubMed ID: 19040789
[TBL] [Abstract][Full Text] [Related]
26. Erythropoietin in bone homeostasis-Implications for efficacious anemia therapy.
Lappin KM; Mills KI; Lappin TR
Stem Cells Transl Med; 2021 Jun; 10(6):836-843. PubMed ID: 33475252
[TBL] [Abstract][Full Text] [Related]
27. Neuroprotective erythropoietin attenuates microglial activation, including morphological changes, phagocytosis, and cytokine production.
Tamura T; Aoyama M; Ukai S; Kakita H; Sobue K; Asai K
Brain Res; 2017 May; 1662():65-74. PubMed ID: 28257780
[TBL] [Abstract][Full Text] [Related]
28. Erythropoietin regulates POMC expression via STAT3 and potentiates leptin response.
Dey S; Li X; Teng R; Alnaeeli M; Chen Z; Rogers H; Noguchi CT
J Mol Endocrinol; 2016 Feb; 56(2):55-67. PubMed ID: 26563310
[TBL] [Abstract][Full Text] [Related]
29. Erythropoietin action in stress response, tissue maintenance and metabolism.
Zhang Y; Wang L; Dey S; Alnaeeli M; Suresh S; Rogers H; Teng R; Noguchi CT
Int J Mol Sci; 2014 Jun; 15(6):10296-333. PubMed ID: 24918289
[TBL] [Abstract][Full Text] [Related]
30. Lineage-restricted recruitment of immature hematopoietic progenitor cells in response to Epo after normal hematopoietic cell transfection with EpoR.
McArthur GA; Longmore GD; Klingler K; Johnson GR
Exp Hematol; 1995 Jul; 23(7):645-54. PubMed ID: 7601257
[TBL] [Abstract][Full Text] [Related]
31. Role of Erythropoietin in Cerebral Glioma: An Innovative Target in Neuro-Oncology.
Torregrossa F; Aguennouz M; La Torre D; Sfacteria A; Grasso G
World Neurosurg; 2019 Nov; 131():346-355. PubMed ID: 31658577
[TBL] [Abstract][Full Text] [Related]
32. [Pleiotropic effects of erythropoietin].
Kes P; Basić-Jukić N; Furić-Cunko V
Acta Med Croatica; 2009 Sep; 63 Suppl 1():46-53. PubMed ID: 20232551
[TBL] [Abstract][Full Text] [Related]
33. Erythroid-specific expression of the erythropoietin receptor rescued its null mutant mice from lethality.
Suzuki N; Ohneda O; Takahashi S; Higuchi M; Mukai HY; Nakahata T; Imagawa S; Yamamoto M
Blood; 2002 Oct; 100(7):2279-88. PubMed ID: 12239135
[TBL] [Abstract][Full Text] [Related]
34. Phospho-PTM proteomic discovery of novel EPO- modulated kinases and phosphatases, including PTPN18 as a positive regulator of EPOR/JAK2 Signaling.
Held MA; Greenfest-Allen E; Su S; Stoeckert CJ; Stokes MP; Wojchowski DM
Cell Signal; 2020 May; 69():109554. PubMed ID: 32027948
[TBL] [Abstract][Full Text] [Related]
35. EPO-independent functional EPO receptor in breast cancer enhances estrogen receptor activity and promotes cell proliferation.
Reinbothe S; Larsson AM; Vaapil M; Wigerup C; Sun J; Jögi A; Neumann D; Rönnstrand L; Påhlman S
Biochem Biophys Res Commun; 2014 Feb; 445(1):163-9. PubMed ID: 24502950
[TBL] [Abstract][Full Text] [Related]
36. Erythroid progenitors differentiate and mature in response to endogenous erythropoietin.
Sato T; Maekawa T; Watanabe S; Tsuji K; Nakahata T
J Clin Invest; 2000 Jul; 106(2):263-70. PubMed ID: 10903342
[TBL] [Abstract][Full Text] [Related]
37. Erythropoietin Reduces Insulin Resistance via Regulation of Its Receptor-Mediated Signaling Pathways in
Pan Y; Yang XH; Guo LL; Gu YH; Qiao QY; Jin HM
Int J Biol Sci; 2017; 13(10):1329-1340. PubMed ID: 29104499
[TBL] [Abstract][Full Text] [Related]
38. Chorioamnionitis disrupts erythropoietin and melatonin homeostasis through the placental-fetal-brain axis during critical developmental periods.
Kitase Y; Madurai NK; Hamimi S; Hellinger RL; Odukoya OA; Ramachandra S; Muthukumar S; Vasan V; Sevensky R; Kirk SE; Gall A; Heck T; Ozen M; Orsburn BC; Robinson S; Jantzie LL
Front Physiol; 2023; 14():1201699. PubMed ID: 37546540
[No Abstract] [Full Text] [Related]
39. The non-haematopoietic biological effects of erythropoietin.
Arcasoy MO
Br J Haematol; 2008 Apr; 141(1):14-31. PubMed ID: 18324962
[TBL] [Abstract][Full Text] [Related]
40. Erythropoietin Signaling in the Microenvironment of Tumors and Healthy Tissues.
Liu W; Varier KM; Sample KM; Zacksenhaus E; Gajendran B; Ben-David Y
Adv Exp Med Biol; 2020; 1223():17-30. PubMed ID: 32030683
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
